These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16007052)

  • 1. [Clinical and prognostic value of therapy with contemporary beta-adrenoblockers in patients after myocardial infarction].
    Bichan NA; Bykova EF; Gorbatovskiĭ IaA; Pakhtusova NI; Mishchenko EP; Kotarova LV
    Kardiologiia; 2005; 45(5):51-2. PubMed ID: 16007052
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and metabolic effects of cardioselective beta-adrenoblockers nebivolol and metoprolol in patients with hypertension and ischemic heart disease associated with type 2 diabetes].
    Makolkin VI; Akhmedova OO; Buval'tsev VI; Gavrilov IuV; Petriĭ VV
    Kardiologiia; 2003; 43(2):40-3. PubMed ID: 12891271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiischemic and metabolic effects of nebivolol and metaprolol CR/XL (betalok ZOK) in patients with postinfarction heart dysfunction].
    Tepliakov AT; Kuznetsova AV; Stepacheva TA; D'iakova ML; Shilov SN; Bolotskaia LA
    Klin Med (Mosk); 2005; 83(4):56-9. PubMed ID: 15941146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Administration of cardioselective beta-adrenoblockers in patients with arterial hypertension and/or ischemic heart disease associated with bronchoobstructive syndrome].
    Ovcharenko SI; Litvinova IV; Mikolkin VI
    Ter Arkh; 2007; 79(9):12-8. PubMed ID: 18038580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nebivolol effects on platelet aggregation and anticoagulation system].
    Novikov TA; Zarudiĭ FA; Zakirova AN
    Kardiologiia; 2003; 43(7):70-6. PubMed ID: 14603912
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethlyarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Menevşe E
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):84; author reply 84. PubMed ID: 18258550
    [No Abstract]   [Full Text] [Related]  

  • 7. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
    Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol: a new beta blocker on the horizon.
    Katira R; Chauhan A
    Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with the superselective third-generation beta-adrenoblocker nebivolol used to treat patients with prior myocardial infarction].
    Bichan NA; Bykova EF; Gorbatovskiĭ IaA; Pakhtusova NI; Mishchenko EP; Onishchenko EG
    Klin Med (Mosk); 2004; 82(8):57-60. PubMed ID: 15468728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X.
    Erdamar H; Sen N; Tavil Y; Yazici HU; Turfan M; Poyraz F; Topal S; Okuyan H; Cemri M; Cengel A
    Coron Artery Dis; 2009 May; 20(3):238-4. PubMed ID: 19396947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of subclinical left ventricular dysfunction by antihypertensive treatment: a prospective trial of nebivolol against metoprolol.
    Vinereanu D; Gherghinescu C; Ciobanu AO; Magda S; Niculescu N; Dulgheru R; Dragoi R; Lautaru A; Cinteza M; Fraser AG
    J Hypertens; 2011 Apr; 29(4):809-17. PubMed ID: 21297499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB; Erdem A; Yalta K; Turgut OO; Yilmaz A; Tandogan I
    Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
    Sen N; Tavil Y; Erdamar H; Yazici HU; Cakir E; Akgül EO; Bilgi C; Erbil MK; Poyraz F; Okyay K; Turfan M; Cemri M
    Anadolu Kardiyol Derg; 2009 Oct; 9(5):371-9. PubMed ID: 19819787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
    Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic analysis of the treatment of heart failure with beta-blockers].
    Díez-Manglano J
    Med Clin (Barc); 2013 Sep; 141(6):265-70. PubMed ID: 23597957
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
    Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
    Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephroprotective properties of third-generation beta-adrenoblockers].
    Kuz'min OB; Belianin VV; Zhezha VV
    Eksp Klin Farmakol; 2014; 77(3):40-3. PubMed ID: 24800526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of nebivolol, metoprolol and enalapril maleate on the state of endothelium-dependent arteriolar vasodilation in patients with essential hypertension].
    Polivoda SN; Cherepok AA; Solov'iuk AO; Sychev RA; Kurilo OA
    Lik Sprava; 2001; (2):138-40. PubMed ID: 11519414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.